Matches in Wikidata for { <http://www.wikidata.org/entity/Q62030840> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- Q62030840 description "clinical trial" @default.
- Q62030840 description "ensayo clínico" @default.
- Q62030840 description "ensayu clínicu" @default.
- Q62030840 description "klinisch onderzoek" @default.
- Q62030840 description "клінічне випробування" @default.
- Q62030840 description "临床试验" @default.
- Q62030840 name "Post Marketing Surveillance to Observe Safety and Effectiveness of CABOMETYX™ in Korea." @default.
- Q62030840 type Item @default.
- Q62030840 label "Post Marketing Surveillance to Observe Safety and Effectiveness of CABOMETYX™ in Korea." @default.
- Q62030840 prefLabel "Post Marketing Surveillance to Observe Safety and Effectiveness of CABOMETYX™ in Korea." @default.
- Q62030840 P1050 Q62030840-AF34A18A-C27A-4CD6-A29F-6F55555595B2 @default.
- Q62030840 P1132 Q62030840-7A420771-466F-44AD-8F9B-4B704E55E032 @default.
- Q62030840 P1476 Q62030840-8436A4A2-26DE-4E40-A7F3-613064C6BB1C @default.
- Q62030840 P2899 Q62030840-C92B2649-9CCA-434F-B2F8-6014919653F6 @default.
- Q62030840 P3098 Q62030840-BA077506-B6BD-4218-B78E-C26E7307A5C8 @default.
- Q62030840 P31 Q62030840-91D3C50E-F053-4EBF-8E3F-68433E6F72C8 @default.
- Q62030840 P580 Q62030840-778938A5-AC24-4758-8DD0-64281D2CB94A @default.
- Q62030840 P582 Q62030840-3D1C33D5-2816-4142-90A1-E0BAEF000819 @default.
- Q62030840 P6153 Q62030840-067554BA-556B-49CE-A7A6-CD05F75B5D08 @default.
- Q62030840 P6153 Q62030840-0DF22A0A-F5DB-473B-BB2A-8E720B92BE5D @default.
- Q62030840 P6153 Q62030840-22A03177-77DF-4220-9144-BB243BB51FEE @default.
- Q62030840 P6153 Q62030840-4CC70B63-B930-4855-84A3-E095AE0F5452 @default.
- Q62030840 P6153 Q62030840-4CDFBFED-AEEF-41FC-8F3C-3AE2BAB4D096 @default.
- Q62030840 P6153 Q62030840-5AF2367D-85C9-457E-A918-F3AE1E6AFDDC @default.
- Q62030840 P6153 Q62030840-8A7B0639-056C-4C5F-B887-9CC8C3CAF065 @default.
- Q62030840 P6153 Q62030840-ACD92FA9-8352-4A65-B094-795D5F391EEB @default.
- Q62030840 P6153 Q62030840-D1A593B3-E54A-4BEF-B22D-BF507E73CF28 @default.
- Q62030840 P6153 Q62030840-D76817D2-B266-4E6D-9CDF-DDF38921B481 @default.
- Q62030840 P6153 Q62030840-DE7710B6-6CF0-4983-B0EC-7113384BD828 @default.
- Q62030840 P6153 Q62030840-E823B59A-D3D9-480C-A5F8-47C45C1E8B89 @default.
- Q62030840 P8005 Q62030840-A6B92647-C233-49FD-9304-812EDD29B232 @default.
- Q62030840 P8363 Q62030840-3E2F84BD-897F-48D0-AA7B-D42C70452108 @default.
- Q62030840 P1050 Q33525 @default.
- Q62030840 P1132 "+422" @default.
- Q62030840 P1476 "Prospective, Post Marketing Surveillance to Observe Safety and Effectiveness of CABOMETYX™ Under the Real Practice Setting in Patients With Renal Cell Carcinoma in Korea." @default.
- Q62030840 P2899 "+18" @default.
- Q62030840 P3098 "NCT03776123" @default.
- Q62030840 P31 Q30612 @default.
- Q62030840 P580 "2019-01-31T00:00:00Z" @default.
- Q62030840 P582 "2021-03-31T00:00:00Z" @default.
- Q62030840 P6153 Q12591204 @default.
- Q62030840 P6153 Q139779 @default.
- Q62030840 P6153 Q16188802 @default.
- Q62030840 P6153 Q30253976 @default.
- Q62030840 P6153 Q30254021 @default.
- Q62030840 P6153 Q39988 @default.
- Q62030840 P6153 Q39997 @default.
- Q62030840 P6153 Q41790 @default.
- Q62030840 P6153 Q4803501 @default.
- Q62030840 P6153 Q489488 @default.
- Q62030840 P6153 Q5587391 @default.
- Q62030840 P6153 Q623851 @default.
- Q62030840 P8005 Q76649708 @default.
- Q62030840 P8363 Q818574 @default.